XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net loss $ (19,377) $ (18,449)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 114 114
Amortization of platform development and intangible assets 7,021 6,399
Amortization of debt discounts 930 660
Loss on impairment of assets 119 257
Change in fair value of contingent consideration 499
Liquidated damages 127 172
Stock-based compensation 6,427 7,367
Deferred income taxes 7 14
Bad debt expense 36 183
Change in operating assets and liabilities net of effect of business combination:    
Accounts receivable 10,303 1,594
Subscription acquisition costs (4,304) 6,150
Royalty fees 3,750
Prepayments and other current assets (7,596) (224)
Other long-term assets 61 52
Accounts payable 2,595 (4,912)
Accrued expenses and other (2,144) (7,444)
Unearned revenue 3,464 (8,358)
Subscription refund liability 95 (553)
Operating lease liabilities (56) (54)
Other long-term liabilities 7 (29)
Net cash used in operating activities (1,672) (13,311)
Cash flows from investing activities    
Purchases of property and equipment (71)
Capitalized platform development (1,188) (1,582)
Payments for acquisition (500)
Net cash used in investing activities (1,688) (1,653)
Cash flows from financing activities    
Repayments under line of credit, net borrowing (4,533) (2,697)
Proceeds from common stock from registered direct offering 11,500
Payments of offering cost from common stock from registered direct offering (69)
Proceeds from issuance of common stock from public offering, net of offering cost 32,058
Payment of taxes from common stock withheld (1,423) (556)
Payment of deferred cash payments (25)
Payment of restricted stock liabilities (710)
Net cash provided by financing activities 5,450 28,095
Net increase in cash, cash equivalents, and restricted cash 2,090 13,131
Cash, cash equivalents, and restricted cash – beginning of period 14,373 9,851
Cash, cash equivalents, and restricted cash – end of period 16,463 22,982
Cash, cash equivalents, and restricted cash    
Cash and cash equivalents 15,961 22,480
Restricted cash 502 502
Total cash, cash equivalents, and restricted cash 16,463 22,982
Supplemental disclosure of cash flow information    
Cash paid for interest 3,252 2,160
Cash paid for income taxes
Noncash investing and financing activities    
Reclassification of stock-based compensation to platform development 307 687
Offering costs included in accrued expenses and other 220 1,568
Issuance of common stock in connection with settlement of liquidated damages 370 7,008
Issuance of common stock upon conversion of Series H convertible preferred stock 511
Issuance of common stock issued in connection with an acquisition 2,000
Deferred cash payments recorded in connection with acquisitions 246
Reclassification to liability upon common stock modification $ 68